• Karin Klooster and Dirk-Jan Slebos.
• University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases, The Netherlands.
• Chest. 2021 May 1; 159 (5): 1833-1842.

AbstractBronchoscopic lung volume reduction with one-way endobronchial valves is a guideline treatment option for patients with advanced emphysema that is supported by extensive scientific data. Patients limited by severe hyperinflation, with a suitable emphysema treatment target lobe and with absence of collateral ventilation, are the responders to this treatment. Detailed patient selection, a professional treatment performance, and dedicated follow up of the valve treatment, including management of complications, are key ingredients to success. This treatment does not stand alone; it especially requires extensive knowledge of COPD for which the most appropriate treatment is discussed in a multidisciplinary approach. We discuss the endobronchial valve treatment for emphysema and provide a guideline for patient selection, treatment guidance, and practice tools, based on our own experience and literature.Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

5 keywords...

hide…